Stoked Bio Licenses Global Rights for Novel Antibiotic from McMaster University
Hamilton, Ontario--(Newsfile Corp. - December 4, 2025) - Stoked Bio Inc., a Canadian biotechnology company focused on the development of novel anti-infectives and cancer therapeutics, announced today it has secured an exclusive, global license from McMaster University for the patents covering Enterololin. Stoked Bio will lead the development of Enterololin, a promising narrow-spectrum antibiotic, as a potential therapeutic for conditions including Crohn's disease.
2025-12-04 9:12 AM EST